A detailed history of Fortitude Advisory Group L.L.C. transactions in Pfizer Inc stock. As of the latest transaction made, Fortitude Advisory Group L.L.C. holds 17,401 shares of PFE stock, worth $458,690. This represents 0.32% of its overall portfolio holdings.

Number of Shares
17,401
Previous 15,655 11.15%
Holding current value
$458,690
Previous $438,000 14.84%
% of portfolio
0.32%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $48,364 - $54,806
1,746 Added 11.15%
17,401 $503,000
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $85,126 - $99,752
-3,370 Reduced 17.71%
15,655 $438,000
Q1 2024

May 02, 2024

SELL
$25.89 - $29.73 $12,427 - $14,270
-480 Reduced 2.46%
19,025 $527,000
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $4,076 - $5,294
156 Added 0.81%
19,505 $561,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $115,748 - $135,298
3,607 Added 22.91%
19,349 $641,000
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $19,793 - $22,900
-548 Reduced 3.36%
15,742 $577,000
Q1 2023

May 05, 2023

SELL
$39.39 - $51.28 $55,461 - $72,202
-1,408 Reduced 7.96%
16,290 $664,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $2,004 - $2,616
48 Added 0.27%
17,698 $907,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $10,108 - $12,340
231 Added 1.33%
17,650 $772,000
Q2 2022

Aug 16, 2022

SELL
$46.53 - $55.17 $15,168 - $17,985
-326 Reduced 1.84%
17,419 $913,000
Q1 2022

May 25, 2022

SELL
$45.75 - $56.69 $96,852 - $120,012
-2,117 Reduced 10.66%
17,745 $919,000
Q4 2021

May 20, 2022

BUY
$41.32 - $61.25 $820,697 - $1.22 Million
19,862 New
19,862 $1.17 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fortitude Advisory Group L.L.C. Portfolio

Follow Fortitude Advisory Group L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortitude Advisory Group L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Fortitude Advisory Group L.L.C. with notifications on news.